Join us in this insightful episode of our new series, Partners in Practice. We delved into the critical role of teamwork in cancer care, focusing on the treatment landscape of metastatic pancreatic cancer.

In this episode, we were joined by Dr. Timothy Brown, a GI medical oncologist from UT Southwestern, and Ms. Heather Klein, a GI-focused nurse practitioner. Together, we explored the latest treatment options, including modified FOLFIRINOX, NALIRIFOX, gemcitabine with nab-paclitaxel, and the emerging role of novel therapies like RAS inhibitors.

Key topics include:

• Overview of current treatment paradigms for metastatic pancreatic cancer
• Discussion of side effects and patient management strategies
• The importance of communication and collaboration within the oncology team
• Insights into the future of pancreatic cancer treatment and the potential of new therapies

Whether you're a healthcare professional, a patient, or simply interested in oncology, this episode offers valuable perspectives on delivering compassionate and effective cancer care.

Listen us on:
Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o

Follow us on social media:

• ⁠X/Twitter: https://x.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/

Don't forget to like, subscribe, and hit the notification bell for more episodes from the Oncology Brothers!

PancreaticCancer, #PartnersInPractice, #RASinhibitors, #OncologyBrothers